TRAW’s Market Whiplash: 14.91% YTD Rise, -7.87% Plunge in 30 Days

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a gain of 14.91%.However, over the last six months, we can see a weaker performance of 15.94%. Over the last 30 days, the price of TRAW has leaped by -7.87%. And in the last five days, it has fallen by -4.80%.

Traws Pharma Inc. had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $1.45 on 05/08/23, while the lowest price during the same period was $0.55 on 10/13/23.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


52-week price history of TRAW Stock

The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Traws Pharma Inc.’s current trading price is -40.91% away from its 52-week high, while its distance from the 52-week low is 55.53%. The stock’s price range for this period has been between $0.55 and $1.45. The Healthcare sector company’s shares saw a trading volume of about 1.38 million for the day, which was higher than the average daily volume of 96380.0 over the last three months.

The Connection Between Financial Performance and Market Capitalization

Traws Pharma Inc. (TRAW) has experienced a quarterly rise of 8.46% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 17.99M and boasts a workforce of 17 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.7478, with a change in price of +0.2058. Similarly, Traws Pharma Inc. recorded 211,543 in trading volume during the last 100 days, posting a change of +31.61%.

TRAW’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for TRAW stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

TRAW Stock Stochastic Average

As of today, the raw stochastic average of Traws Pharma Inc. over the past 50 days is 45.96%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 37.64%. Additionally, the Stochastic %K and %D values for the company were 56.88% and 64.21%, respectively, over the past 20 days.

On Key

Related Posts